A Retrospective Study on the Adverse Effects of Chemotherapy in Breast Cancer-A Multicenter Study

Published on:June 2019
Indian Journal of Pharmacy Practice, 2019; 12(2):111-116
Research Article | doi:10.5530/ijopp.12.2.24

A Retrospective Study on the Adverse Effects of Chemotherapy in Breast Cancer-A Multicenter Study

Authors and affiliation (s):

Devender Kodati*, Sowmya Tirumala, Rishitha Krishna Kantheti, Joseph Priyatham Reddy Thumma

Department of Pharmacy Practice, St. Peter’s Institute of Pharmaceutical Sciences, Warangal-506001, Telangana State, INDIA.


Objective: The present study is a retrospective observational and a non-comparative descriptive study, to evaluate the clinical manifestations, risk factors, diagnosis, treatment regimen and mainly the adverse effects associated with the chemotherapeutic drugs, where the case sheets of the breast cancer patients were reviewed properly and the required data is obtained and finding of adverse effects was considered as the primary parameters. Methodology: A total of 353 patients were enrolled in the study. The required demographic details and laboratory data were reviewed from the case sheets. During chemotherapy, some of the patients were given with AC, T (Doxorubicin, cyclophosphamide, paclitaxel) regimen and few patients were given with CAF (Cyclophosphamide, Doxorubicin, 5-FU) regimen. The reports were re-reviewed for adverse effects after chemotherapy. Results: Among 353 patients, 344 patients have shown adverse effects and 9 patients were without any adverse effects during chemotherapy. We have identified 1,157 adverse effects in a total of 344 patients, among them 16.5% were found to be cardiac effects, 60.5% were found to be haematological effects and 22.6% were found to be in USG abdomen. Conclusion: Among 353 patients, age group between 49-58 years has shown higher adverse effects (25.85%) and the least adverse effects were presented by the age group between 18-28 years (6.52%).

Key words: Breast cancer, Chemotherapy, Adverse effects, Doxorubicin, Cyclophosphamide, Paclitaxel.


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs